Drugs / Bellis perennis
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00405626 | Apr → Sep 2007 | hemorrhagic disease | Hadassah Medical Organization | Unknown | No outcome recorded |
| Comparator or background therapy3 trials | ||||||
| Phase 2/3 | NCT00725569 Comparator | Aug 2008 → Apr 2009 | — | Shaare Zedek Medical Center | Completed | No outcome recorded |
| Phase 3 | NCT01156194 Comparator | Jan 2011 → Jan 2012 | — | Shaare Zedek Medical Center | Completed | No outcome recorded |
| — | NCT03512639 Comparator | Jan 2016 → Aug 2017 | — | Shaare Zedek Medical Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bellis perennis | “Homeopathic medication (Arnica montana and the Bellis perennis) were given to women in the study group following mastectomy and reconstruction to reduce post operative seroma” NCT03512639 ↗3“The effect of the homeopathic remedies Arnica montana and Bellis perennis” PMID 16036165 ↗ Jun 2005 “Arnica montana C6 and Bellis perennis C6” NCT01156194 ↗ |
| Modality | Other / unclassified | “homeopathic remedy” NCT00725569 ↗ |